Doug Wintemute is a staff writer for Forbes Advisor. After completing his master’s in English at York University, he began his writing career in the higher education space. Over the past decade, Doug ...

As the MDGs era comes to a conclusion with the end of the year, 2016 ushers in the official launch of the bold and transformative 2030 Agenda for Sustainable Development adopted by world leaders last ...

Research within this pillar aimed to identify the global impacts of reforms that appear to be a particularly high priority and to generate new research that can provide guidance on the policy reforms ...

The Global Financial Development Database is an extensive dataset of financial system characteristics for 214 economies. It contains annual data, starting from 1960. It has been last updated in ...

The way in which we develop the American landscape and its urban areas is a critical component to creating livable and sustainable cities. The footprint of major metropolitan areas, suburbs, and small ...

Dr. JeFreda R. Brown is a financial consultant, Certified Financial Education Instructor, and researcher who has assisted thousands of clients over a more than two-decade career. She is the CEO of ...

In 2025, the world razed less forest than any other year in the last decade. The bad news: global warming is making wildfires more frequent and intense. By Sachi Kitajima Mulkey and Harry Stevens In a ...

Strengthening the capacity of institutions—including central banks, finance ministries, revenue administrations, statistical agencies, and financial sector supervisory agencies—results in more ...

Why more and more companies worldwide are embracing this planning process Suzanne is a content marketer, writer, and fact-checker. She holds a Bachelor of Science in Finance degree from Bridgewater ...

Democracy is in crisis, with falling trust in institutions and a rise in authoritarian leaders. Learn how a renewed focus on engaging citizens in democratic systems and institutions can help to arrest ...

Drug development describes the process of developing a new drug that effectively targets a specific weakness in a cell. This process involves specific pre-clinical development and testing, followed by ...